Spolupráce

pplk. RNDr. Michal Kroča, Ph.D.

Military Medical Agency, Military Health Institute, Biological Defence Department at Těchonín
Antitoxin therapy.


Petr Jansa PhD, Tomáš Cihlář PhD, Gabriel Birkuš PhD, Richard Mackman PhD

Gilead Sciences, Inc., Foster City, California, U.S.A.
Biological activity screening, pharmacokinetic profiles of active compounds and mutual general cooperation within Gilead Sciences & IOCB Research Centre.


Prof. Erik De Clercq, Prof. Jan Balzarini, Prof. Johan Neyts, Dr. Robert Snoeck, Dr. Lieve Naesens, Dr. Graciela Andrei

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
Antiviral screening.


Dr. Luke Guddat

The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072 QLD, Australia
Antimalarial program.

Dr. Nicholas P. West,

The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072 QLD, Australia
Tuberculosis Research.

Mjr. Michael D. Edstein

Australian Army Malaria Institute, Enoggera, Brisbane, Queensland 4051, Australia
Antimalarial program.


Dr. Zdeněk Zídek

Institute of Experimental Medicine, Academy of Sciences of the Czech Republic
Immunomodulatory activity.


Dr. Helena Mertlíková-Kaiserová

IOCB Prague
Cytostatic activity, inhibitory activity towards thymidine phosphorylase.


Martin Dračínský PhD,

IOCB Prague
NMR spectroscopy.


RNDr. Alena Panicucci Zíková, PhD.

Laboratory of Functional Biology of Protists, Institute of Parasitology, Biology Centre, ASCR, v.v.i.